Molecular Partners Ag (MOLN) Accumulated Expenses (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Accumulated Expenses for 7 consecutive years, with $7235.5 the latest figure, recorded in Q1 2026.

• Quarterly Accumulated Expenses rose 21.62% year-over-year to $7235.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7235.5 (up 21.62% YoY) and the FY2025 annual result came in at $10078.2, down 99.89% from the prior year.
• Accumulated Expenses retreated to $7235.5 in Q1 2026 per MOLN's latest filing, from $10078.2 in the prior quarter.
• Over the last five years, Accumulated Expenses for MOLN reached as high as $8.8 million in Q4 2024 and fell as low as $5256.6 in Q1 2023.
• A 5-year average of $2.8 million and a median of $10078.2 in 2025 frame the typical range for Accumulated Expenses.
• The largest YoY upside for Accumulated Expenses was 32.97% in 2025 against a maximum downside of 99.89% in 2025.
• Year by year, Accumulated Expenses stood at $7.8 million in 2022, then gained by 9.27% to $8.5 million in 2023, then grew by 3.43% to $8.8 million in 2024, then plunged by 99.89% to $10078.2 in 2025, then dropped by 28.21% to $7235.5 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $7235.5, $10078.2, and $10494.7 for Q1 2026, Q4 2025, and Q3 2025 respectively.